Results 1 to 10 of about 7,405 (191)

KSNM60: The History of Radiopharmaceutical Sciences in Korea [PDF]

Nuclear Medicine and Molecular Imaging, 2022
A number of researchers in Korea have tried to set-up the production of radionuclides and develop new radiopharmaceuticals for several decades. Thanks to their 60-year endeavor to advance the field of radiopharmaceutical sciences, now we have a lot of research units and facilities in Korea.
Yun－Sang Lee, Kyo Chul Lee, Dong Wook Kim   +2 more
exaly   +5 more sources

Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative. [PDF]

Nucl Med Biol, 2019
The radiopharmaceutical sciences are a relatively recent addition to the field of natural and life sciences. After early basic research following the discovery of radioactivity at the turn of the 20th century, the wider use of radionuclides, especially ...
Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD.   +10 more
europepmc   +5 more sources

Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications [PDF]

Molecules, 2021
Biomedical imaging technologies offer identification of several anatomic and molecular features of disease pathogenesis. Molecular imaging techniques to assess cellular processes in vivo have been useful in advancing our understanding of several vascular
Kevin Prigent, Jonathan Vigne
doaj   +5 more sources

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology [PDF]

Lancet Oncology, The
This paper is the first of a Series on theranostics that summarises the current landscape of the radiopharmaceutical sciences as they pertain to oncology. In this Series paper, we describe exciting developments in radiochemistry and the production of radionuclides, the development and translation of theranostics, and the application of artificial ...
Aruna Korde
exaly   +6 more sources

How green are radiopharmaceutical sciences? [PDF]

Nuclear Medicine and Biology
The rapid growth of radiopharmaceutical sciences, driven by regulatory approvals of theranostic agents and the expanding role of PET imaging, underscores the need for sustainable and green practices. While radiopharmaceuticals offer high precision and targeted therapy with minimal systemic toxicity, the field faces challenges related to increasing ...
Matthias M Herth, Verena Hugenberg, Peter J H Scott   +2 more
exaly   +5 more sources

Highlight selection of radiochemistry and radiopharmacy developments by editorial board [PDF]

EJNMMI Radiopharmacy and Chemistry
Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Jun Toyohara, Danielle Vugts, Oliver C. Kiss, Sergio Todde, Xiang-Guo Li, Zhibo Liu, Zhi Yang, Nic Gillings, Emiliano Cazzola, Wiktor Szymanski, Nick van der Meulen, Raymond Reilly, Carlotta Taddei, Ralf Schirrmacher, Zijing Li, Yohannes Jorge Lagebo, Naoual Bentaleb, Marta de Souza Albernaz, Suzanne Lapi, Caterina Ramogida, Archana Mukherjee, Javier Ajenjo, Winnie Deuther-Conrad, Cécile Bourdeau   +23 more
doaj   +2 more sources

Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight [PDF]

Nuclear Medicine and Biology, 2017
Over recent years, within the community of radiopharmaceutical sciences, there has been an increased incidenceof incorrect usage of established scientific terms and conventions, and even the emergence of ‘self-invented’ terms.In order to address these ...
Heinz H Coenen, Antony D Gee, Michael Adam   +2 more
exaly   +2 more sources

Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy

Pharmaceuticals, 2014
The fields of molecular biology, immunology and genetics have generated many important developments that advance the understanding of the induction and progression of oncological, cardiological and neurological diseases as well as the identification of ...
Klaus Kopka
doaj   +2 more sources

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics. [PDF]

Lancet Oncol
Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th century, the systematic use of radionuclides in medicine only gradually increased over the subsequent hundred years.
Scott AM, Zeglis BM, Lapi SE, Scott PJH, Windhorst AD, Abdel-Wahab M, Giammarile F, Piaez D, Jalilian A, Knoll P, Korde A, Vichare S, Ayati N, Lee ST, Lyashchenko SK, Zhang J, Urbain JL, Lewis JS.   +17 more
europepmc   +3 more sources

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

EJNMMI Radiopharmacy and Chemistry, 2023
Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Jean DaSilva, Clemens Decristoforo, Robert H. Mach, Guy Bormans, Giuseppe Carlucci, Mohammed Al-Qahtani, Adriano Duatti, Antony D. Gee, Wiktor Szymanski, Sietske Rubow, Jeroen Hendrikx, Xing Yang, Hongmei Jia, Junbo Zhang, Peter Caravan, Hua Yang, Jan Rijn Zeevaart, Miguel Avila Rodriquez, Ralph Santos Oliveira, Marcela Zubillaga, Tamer Sakr, Sarah Spreckelmeyer   +21 more
doaj   +2 more sources